Response

Affiliations

¹ Inova Fairfax Hospital, Falls Church, VA. Electronic address: steven.nathan@inova.org.
² Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

Comment

Steven D Nathan et al. Chest. 2023 Jul.

. 2023 Jul;164(1):e22.

doi: 10.1016/j.chest.2023.04.016.

¹ Inova Fairfax Hospital, Falls Church, VA. Electronic address: steven.nathan@inova.org.
² Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

No abstract available

Comment on

Inhaled Treprostinil Dosage in Pulmonary Hypertension Associated With Interstitial Lung Disease and Its Effects on Clinical Outcomes.
Nathan SD, Deng C, King CS, DuBrock HM, Elwing J, Rajagopal S, Rischard F, Sahay S, Broderick M, Shen E, Smith P, Tapson VF, Waxman AB. Nathan SD, et al. Chest. 2023 Feb;163(2):398-406. doi: 10.1016/j.chest.2022.09.007. Epub 2022 Sep 15. Chest. 2023. PMID: 36115497 Free PMC article. Clinical Trial.
Treprostinil and Clinical Outcome in Pulmonary Hypertension and Interstitial Lung Disease: Is All Clear?
Carbone RG, Monselise A, Puppo F. Carbone RG, et al. Chest. 2023 Jul;164(1):e21. doi: 10.1016/j.chest.2023.04.015. Chest. 2023. PMID: 37423704 No abstract available.